Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buru...
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
About this item
Full title
Author / Creator
Phillips, Richard O , Robert, Jérôme , Abass, Kabiru Mohamed , Thompson, William , Sarfo, Fred Stephen , Wilson, Tuah , Sarpong, Godfred , Gateau, Thierry , Chauty, Annick , Omollo, Raymond , Ochieng Otieno, Michael , Egondi, Thaddaeus W , Ampadu, Edwin O , Agossadou, Didier , Marion, Estelle , Ganlonon, Line , Wansbrough-Jones, Mark , Grosset, Jacques , Macdonald, John M , Treadwell, Terry , Saunderson, Paul , Paintsil, Albert , Lehman, Linda , Frimpong, Michael , Sarpong, Nanaa Francisca , Saizonou, Raoul , Tiendrebeogo, Alexandre , Ohene, Sally-Ann , Stienstra, Ymkje , Asiedu, Kingsley B , van der Werf, Tjip S , Osei Mireku, Samuel , Abotsi, Justice , Adu Poku, Joseph Ken , Asamoah-Frimpong, Richard , Osei-Wusu, Bright , Sarpong, Edward , Konadu, Beatrice , Opoku, Ernest , Forson, Mark , Ndogyele, Mathias , Ofori, Elizabeth , Aboagye, Felicity , Berko, Thomas , Amofa, George , Nsiah, Anastasia , Mensah-Bonsu, Joyce , Ofori Nyarko, Joseph , Amoako, Yaw Ampem , Koranteng Tannor, Elliot , Boakye-Appiah, Justice , Dzibordzi Loglo, Aloysius , Sarpong-Duah, Mabel , Agbavor, Bernadette , Ardent, Marie Françoise , Yamadjako, Arnaud , Adanmado Gersande, Naomi , Adeye, Ambroise , Kindjinou, Martial , Akpolan , Kiki, Maxime , Sodjinou, Espoir , Guegnard, Clémence , Klis, Sandor-Adrian , Velding, Kristien , Omansen, Till , Ofori-Adjei, David , Eyangoh, Sarah , Knell, Alan , Faber, William and study team
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifampicin 10 mg/kg plus intramuscular streptomycin 15 mg/kg once daily for 8 weeks (RS8) is highly effective, but st...
Alternative Titles
Full title
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
Authors, Artists and Contributors
Author / Creator
Robert, Jérôme
Abass, Kabiru Mohamed
Thompson, William
Sarfo, Fred Stephen
Wilson, Tuah
Sarpong, Godfred
Gateau, Thierry
Chauty, Annick
Omollo, Raymond
Ochieng Otieno, Michael
Egondi, Thaddaeus W
Ampadu, Edwin O
Agossadou, Didier
Marion, Estelle
Ganlonon, Line
Wansbrough-Jones, Mark
Grosset, Jacques
Macdonald, John M
Treadwell, Terry
Saunderson, Paul
Paintsil, Albert
Lehman, Linda
Frimpong, Michael
Sarpong, Nanaa Francisca
Saizonou, Raoul
Tiendrebeogo, Alexandre
Ohene, Sally-Ann
Stienstra, Ymkje
Asiedu, Kingsley B
van der Werf, Tjip S
Osei Mireku, Samuel
Abotsi, Justice
Adu Poku, Joseph Ken
Asamoah-Frimpong, Richard
Osei-Wusu, Bright
Sarpong, Edward
Konadu, Beatrice
Opoku, Ernest
Forson, Mark
Ndogyele, Mathias
Ofori, Elizabeth
Aboagye, Felicity
Berko, Thomas
Amofa, George
Nsiah, Anastasia
Mensah-Bonsu, Joyce
Ofori Nyarko, Joseph
Amoako, Yaw Ampem
Koranteng Tannor, Elliot
Boakye-Appiah, Justice
Dzibordzi Loglo, Aloysius
Sarpong-Duah, Mabel
Agbavor, Bernadette
Ardent, Marie Françoise
Yamadjako, Arnaud
Adanmado Gersande, Naomi
Adeye, Ambroise
Kindjinou, Martial
Akpolan
Kiki, Maxime
Sodjinou, Espoir
Guegnard, Clémence
Klis, Sandor-Adrian
Velding, Kristien
Omansen, Till
Ofori-Adjei, David
Eyangoh, Sarah
Knell, Alan
Faber, William
study team
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7181188
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7181188
Other Identifiers
ISSN
0140-6736,1474-547X
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(20)30047-7
